Investors & Partners – synfini

Partners

Multispan utilizes biologically relevant cell-based assays to generate high-quality data with fast turnaround. Together, we are able to offer a seamless, end-to-end solution for rapid DMTA cycles for faster analysis, high-quality hits, and an efficient path to preclinical candidates.

Investors

JSL invests in late seed and growth-stage healthcare companies leveraging AI, data, and software to transform the world's most important industry.

Learn More

Ferocity Capital, a venture capital firm focused on science and cybersecurity, has raised a series of funds starting in 2018. Ferocity uniquely validates disruptive technologies with prospective clients before investing.

Foothill Ventures is a $300M fund that bets on highly technical, early-stage companies in frontier tech at the Seed and Series A stages.

Learn More

Trust Ventures is an early stage investor in highly regulated industries.

WERU Investment is a Tokyo-based early-stage venture capital firm founded in 1998 as Japan’s first venture capital firm with origins in academia. The firm focuses on investments in global deep technology ventures through a hypothesis-driven research approach.

Global Innovation Labs (GIL) is the external venture fund and global commercialization initiative for SRI, focused on translating breakthrough research and frontier intellectual property into globally scalable venture backed companies.

Gaingels is a venture capital syndicate with a focus on companies that embrace diversity and inclusion.

Investors & Partners